Deep Genomics to Participate in Citi PCA

Deep Genomics

Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today that its Founder and Chief Executive Officer, Brendan Frey, Ph.D., F.R.S.C., will participate in a panel discussion during the Citi PCA – Private Company Digital Health Conference *VIRTUAL* on May 20, 2021.


Session: Artificial Intelligence in Drug Discovery

Date and time: Thursday, May 20, 2021 from 1:30 – 2:00 p.m. EDT

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to

Related posts

Reveal Genomics®️ Presents New Validation Data of Her2dx

PR Newswire

Genomics Global Market Report 2022

Business Wire

Imagia Canexia Health Achieves First CE-IVD Status in the E.U.

Business Wire